OPEN END-TURBO-OPTIONSSCHEIN - RESMED | Real-time Bid/Ask 12:42:33 2024-05-31 pm EDT | ||
| 1.72 EUR / 1.75 EUR | -14.53% |
|
| Current month | -19.12% | ||
| 1 month | -19.12% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 1.72 | -15.27% |
| 24-05-30 | 2.03 | +18.02% |
| 24-05-29 | 1.72 | -6.52% |
| 24-05-28 | 1.84 | -23.97% |
| 24-05-27 | 2.42 | +1.68% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 12:41 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | HSBC |
| WKN | HS697W |
| ISIN | DE000HS697W9 |
| Date issued | 2024-04-26 |
| Strike | 189.1 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.62 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.18 € |
|---|---|
| Lowest since issue | 1.61 € |
| Spread | 0.03 € |
| Spread % | 1.71% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
209.3
USD
Average target price
216.6
USD
Spread / Average Target
+3.49%
- Stock Market
- Certificates
- Certificat
